|
| Monday, November 21, 2011 |
|
|
Omnicare Certifies Substantial Compliance with Second Request; Enters into Timing Agreement with FTC |
| Omnicare, Inc. (NYSE:OCR) today announced that it has certified substantial compliance with the Request for Additional Information (the "Second Request") from the United States Federal Trade Commission ("FTC") pursuant to the Hart-Scott-Rodino Antitrust Improvements Act of 1976, as amended. more info >> |
|
| Thursday, October 27, 2011 |
|
|
Omnicare Enters Into Confidentiality and Joint Defense Agreement with PharMerica |
| Omnicare, Inc. (NYSE:OCR) today confirmed that it has entered into a confidentiality and joint defense agreement with PharMerica Corporation (NYSE:PMC). more info >> |
|
| Tuesday, October 25, 2011 |
|
|
Omnicare Reports Third-Quarter 2011 Financial Results |
| Omnicare, Inc. (NYSE:OCR) reported today financial results for its third quarter ended September 30, 2011. more info >> |
|
| Thursday, October 6, 2011 |
|
|
Omnicare Comments on Proposed CMS Changes Related to Consultant Pharmacists |
| Omnicare, Inc. (NYSE:OCR) today commented on the Centers for Medicare and Medicaid Services' (CMS) request for comments regarding its consideration of changes to the Conditions of Participation for Long Term Care Facilities released on October 3, 2011. more info >> |
|
| Wednesday, October 5, 2011 |
|
|
Omnicare Extends Tender Offer for PharMerica Until December 2, 2011 |
| Omnicare, Inc. (NYSE:OCR) today announced that it has extended its offer to purchase all outstanding shares of PharMerica Corporation (NYSE: PMC) common stock for $15.00 per share in cash to 5:00 p.m., New York City time, on December 2, 2011, unless further extended. more info >> |
|
| Tuesday, October 4, 2011 |
|
|
Omnicare to Release Third-Quarter 2011 Financial Results and Hold Conference Call on Tuesday, October 25, 2011 |
| Omnicare, Inc. (NYSE:OCR), will release its financial results for the third-quarter ended September 30, 2011, before the market opens on Tuesday, October 25, 2011. more info >> |
|
|
|
|
